Genesis IBRC India Limited, a company specializing in pharmaceutical research and development services, has announced a significant change to its board leadership. Mr. Padmanaban Krishnamoorthy has been appointed as an Additional Non-Executive Director and has been further designated as the Chairperson of the company. This appointment is expected to provide the company with seasoned strategic guidance as it navigates the competitive landscape of clinical research and drug development services in 2026.
Trending
- Pernod Ricard India Appoints Sonia Arora as Director of Consumer Insights
- PM Narendra Modi Becomes India’s Longest-Serving Head of Government
- Whole-time Director Indirakumar Resigns from Indrayani Biotech Board
- Secretary Debashree Mukherjee Assigned Additional Charge as Chairperson, NCVET
- Chief Growth Officer Amber Faulkner Joins Droga5 London
- Minister Laljit Singh Bhullar Resigns from Punjab Cabinet Following Official’s Suicide
- Sagarsoft (India) Appoints Finance Veteran Kanakadhara Srinivasan to its Board
- IAS Pramod Kumar Meherda Assigned Additional Charge as CEO, NRAA
